Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
MapLight Therapeutics, Inc. (MPLT) had Return on Equity of -35.16% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-161.15M |
|
-- |
|
-- |
|
$169.08M |
|
$-169.08M |
|
$7.93M |
|
$-161.15M |
|
$-161.15M |
|
$-161.15M |
|
$-161.15M |
|
$-161.15M |
|
$-161.15M |
|
$-169.08M |
|
$-170.61M |
|
8.68M |
|
8.68M |
|
$-18.56 |
|
$-18.56 |
|
| Balance Sheet Financials | |
$324.67M |
|
$1.09M |
|
$154.84M |
|
$479.51M |
|
$16.23M |
|
-- |
|
$4.91M |
|
$21.14M |
|
$458.37M |
|
$458.37M |
|
$458.37M |
|
44.02M |
|
| Cash Flow Statement Financials | |
$-138.14M |
|
$-323.21M |
|
$469.82M |
|
$38.46M |
|
$46.94M |
|
$8.48M |
|
$36.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-138.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-35.16% |
-35.16% |
|
-33.61% |
|
-35.16% |
|
$10.41 |
|
$-15.97 |
|
$-15.91 |
|